Cargando…
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127096/ https://www.ncbi.nlm.nih.gov/pubmed/30190453 http://dx.doi.org/10.1038/s41408-018-0117-0 |
| _version_ | 1783353408560824320 |
|---|---|
| author | Gore, Lia Locatelli, Franco Zugmaier, Gerhard Handgretinger, Rupert O’Brien, Maureen M. Bader, Peter Bhojwani, Deepa Schlegel, Paul-Gerhardt Tuglus, Catherine A. von Stackelberg, Arend |
| author_facet | Gore, Lia Locatelli, Franco Zugmaier, Gerhard Handgretinger, Rupert O’Brien, Maureen M. Bader, Peter Bhojwani, Deepa Schlegel, Paul-Gerhardt Tuglus, Catherine A. von Stackelberg, Arend |
| author_sort | Gore, Lia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6127096 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61270962018-09-07 Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia Gore, Lia Locatelli, Franco Zugmaier, Gerhard Handgretinger, Rupert O’Brien, Maureen M. Bader, Peter Bhojwani, Deepa Schlegel, Paul-Gerhardt Tuglus, Catherine A. von Stackelberg, Arend Blood Cancer J Correspondence Nature Publishing Group UK 2018-08-22 /pmc/articles/PMC6127096/ /pubmed/30190453 http://dx.doi.org/10.1038/s41408-018-0117-0 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Gore, Lia Locatelli, Franco Zugmaier, Gerhard Handgretinger, Rupert O’Brien, Maureen M. Bader, Peter Bhojwani, Deepa Schlegel, Paul-Gerhardt Tuglus, Catherine A. von Stackelberg, Arend Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia |
| title | Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia |
| title_full | Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia |
| title_fullStr | Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia |
| title_full_unstemmed | Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia |
| title_short | Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia |
| title_sort | survival after blinatumomab treatment in pediatric patients with relapsed/refractory b-cell precursor acute lymphoblastic leukemia |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127096/ https://www.ncbi.nlm.nih.gov/pubmed/30190453 http://dx.doi.org/10.1038/s41408-018-0117-0 |
| work_keys_str_mv | AT gorelia survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT locatellifranco survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT zugmaiergerhard survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT handgretingerrupert survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT obrienmaureenm survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT baderpeter survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT bhojwanideepa survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT schlegelpaulgerhardt survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT tugluscatherinea survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia AT vonstackelbergarend survivalafterblinatumomabtreatmentinpediatricpatientswithrelapsedrefractorybcellprecursoracutelymphoblasticleukemia |